{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-004362","form_type":"8-K","ticker":"DWTX","cik":"0001818844","company_name":"Dogwood Therapeutics, Inc.","filed_at":"2025-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.868813+00:00","generated_at":"2026-05-23T22:45:01.806291+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Dogwood Therapeutics regains Nasdaq minimum equity compliance after $19.9M debt swap and $4.8M offering","bullets":["Regained compliance with Nasdaq minimum stockholders' equity requirement ($2.5M).","Debt exchange with Conjoint canceled ~$19.9M debt for Series A-1 preferred stock.","Stock offering raised ~$4.8M gross proceeds from institutional investors.","Cash position $17.5M as of Q1 2025, no debt.","Shares outstanding: 1,911,128 as of March 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-004362","json":"https://secwatch.observer/filing/0001558370-25-004362.json","markdown":"https://secwatch.observer/filing/0001558370-25-004362.md","text":"https://secwatch.observer/filing/0001558370-25-004362.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818844/000155837025004362/0001558370-25-004362-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818844/000155837025004362/dwtx-20250403x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T22:45:01.806291+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}